Recent Pharmaceutical and Biotechnology Transactions Announcement Date Target/Issuer Buyers/Investors/Sellers Transaction Types Status Value ($mm) 09/17/2021 Biotest Aktiengesellschaft Grifols, S.A. Merger/Acquisition Announced 1,274.4 09/16/2021 Acino International AG Abu Dhabi Developmental Holding Company PJSC Merger/Acquisition Announced - 09/16/2021 Klifovet AG Argenta Limited Merger/Acquisition Closed - 09/16/2021 SynBiotic SE Apeiron Investment Group Ltd. Merger/Acquisition Closed - 09/15/2021 Facilities in Colorado Can B Corp. Merger/Acquisition Effective - 09/15/2021 Nearmedic International Limited Sberbank of Russia; Sistema Public Joint Stock Financial Merger/Acquisition Closed 81.4 Corporation 09/13/2021 Centro Veterinario y Agricola Ltda. Virbac SA Merger/Acquisition Closed 17.7 09/13/2021 All the assets of L&G USA, Inc. Resonate Blends, Inc. Merger/Acquisition Announced - 09/13/2021 TetraGenetics, Inc. AbCellera Biologics Inc. Merger/Acquisition Closed - 09/13/2021 First Wave Bio, Inc. AzurRx BioPharma, Inc. Merger/Acquisition Closed 225.3 09/13/2021 Moellerup Brands A/S Danish Agro a.m.b.a. Merger/Acquisition Announced - 09/16/2021 Nanjing IASO Biotherapeutics CDH Investment Management Company Limited; Hillhouse Private Placement Closed 108.0 Investment Management, Ltd.; CCB International Asset Management Ltd.; ShenZhen Co-Stone Asset Management Co., Ltd.; Plaisance Capital LLC; Everbright Limited; GL Ventures 09/16/2021 VLF Holdings LLC Private Placement Announced 0.3 09/16/2021 Guangzhou Reforgene Technology Co., Ltd. Sinovation Ventures (Beijing) Enterprise Management Limited; China Private Placement Closed 31.0 Merchants Securities Co. Ltd., Investment Arm; Yuan-sheng Suzhou Industrial Park Venture Capital Management Co., Ltd.; BioTrack Capital 09/16/2021 Aelix Therapeutics SL CDTI; Caixa Capital Risc, SGEIC, S.A.; Ysios Capital Partners, Private Placement Closed 2.2 SGEIC, S.A.U.; Ysios BioFund II Innvierte, FCR; Caixa Innvierte Start, FCR 09/16/2021 Amolyt Pharma SAS Life Sciences Partners BV; OrbiMed Advisors LLC; Eurazeo SE; Private Placement Closed 80.0 Andera Partners; Turenne Santé; Bpifrance Investissement SAS; Novo Holdings A/S; Credit Agricole Creation; Sectoral Asset Management Inc; Crédit Agricole Régions Investissement SAS; Pontifax Ltd.; Partners Innovation Management Co., LLC; Kurma Partners SA; ATEM Capital; InnoBio 2, FCPI 09/16/2021 Bantam Pharmaceutical LLC Private Placement Closed 25.0 09/16/2021 Yiming (Beijing) Cell Biotechnology Co., Ltd. IDG Ventures; Shenzhen Co-win Venture Capital Investments Private Placement Closed 31.0 Limited; Huagai Capital Co., Ltd.; Jiangsu Addor Equity Investment Fund Management Co., Ltd.; Beijing FOF Capital Co.,Ltd.; Ming Bioventures; Shenzhen Qihang Capital Investment Fund Management Co 09/16/2021 Gritstone bio, Inc. Frazier Management, L.L.C.; Gilead Sciences, Inc.; Redmile Group, Private Placement Announced 55.0 LLC; Frazier Life Sciences Public Fund, L.P. 09/15/2021 Momentum Bioscience Ltd Intuitive Investments Group Plc Private Placement Announced 5.4 09/15/2021 Prenetics Group Limited Private Placement Announced 60.0 09/15/2021 Vincerx Pharma, Inc. Deerfield Management Company, L.P.; Rock Springs Capital Private Placement Announced 50.8 Management LP; Point72 Asset Management, L.P.; Sphera Healthcare US Inc. 09/15/2021 Aptinyx Inc. Private Placement Announced 50.0 09/14/2021 ROME Therapeutics, Inc. Arch Venture Partners, L.P.; Partners Innovation Management Co., Private Placement Closed 77.0 LLC; GV Management Company, LLC; Andreessen Horowitz LLC; Casdin Capital, LLC; Alexandria Venture Investments, LLC; Section 32, LLC; Sanofi Ventures 09/14/2021 AgBiome, LLC Arch Venture Partners, L.P.; Polaris Venture Partners, Inc.; University Private Placement Closed 116.0 of Texas Investment Management Company; The Mosaic Company; Fidelity Management & Research Company LLC; Bayer Growth Ventures; Blue Horizon Corporation; Pontifax Agtech Management, Llc; Novalis LifeSciences Investments LLC 09/14/2021 Vanqua Bio, Inc. Eli Lilly and Company; Pontifax Ltd.; Citadel Advisors LLC; Omega Private Placement Closed 85.0 Fund Management, LLC; Citadel Multi-Strategy Equities Master Fund Ltd.; Casdin Capital, LLC; OrbiMed Capital LLC; Avoro Capital Advisors LLC; Osage University Partners; Logos Capital 09/14/2021 Skyhawk Therapeutics, Inc. Fidelity Management & Research Company LLC Private Placement Closed 133.0 09/14/2021 NIMGenetics Genómica y Medicina S.L. Apposite Capital LLP Private Placement Closed 7.1 09/14/2021 SugarBud Craft Growers Corp. Private Placement Closed 0.3 09/14/2021 Life Science Institute LLC KEEN Growth Capital; Balanced Breakfast Fund Private Placement Closed 1.6 09/14/2021 Biocreatech Volcanics Venture Private Placement Closed 3.1 09/14/2021 Grown Rogue International Inc. Private Placement Announced 0.8 09/14/2021 Touchlight Genetics Ltd. Novator Partners LLP; Bridford Investments Limited Private Placement Closed 127.4 09/14/2021 Alpine Immune Sciences, Inc. Frazier Management, L.L.C.; OrbiMed Advisors LLC; Biotechnology Private Placement Announced 91.0 Value Fund L.P.; BVF Partners, L.P.; Biotechnology Value Fund II, L.P.; 667, L.P.; Baker Brothers Life Sciences, L.P.; Baker Bros. Advisors LP; Omega Fund Management, LLC; Decheng Capital LLC; OrbiMed Private Investments VI, LP; Biotechnology Value Trading Fund OS LP; MSI BVF SPV, LLC; Decheng Capital China Life Sciences USD Fund III, L.P.; Omega Fund VI, L.P.; Avidity Partners Management, L.P.; Logos Global Management, L.P.; Logos Global Master Fund, LP; OrbiMed Genesis Master Fund, L.P.; Avidity Capital Fund II LP; Avidity Master Fund LP; TCG Crossover Management, LLC; TCG Crossover Fund I, L.P.; Avidity Capital HL Sub Fund III LLC; Frazier Life Sciences Public Fund, L.P. 09/13/2021 TreeFrog Therapeutics Leonard Green & Partners, L.P.; Bristol-Myers Squibb Company; Private Placement Closed 75.6 Bpifrance Investissement SAS; Xange Private Equity, S.A.; Large Venture Fund 09/13/2021 LegenDairy Foods GmbH Grazia Equity GmbH; Merck Ventures B.V.; Agronomics Limited; EQT Private Placement Closed 50.0 Ventures; Happiness Capital; CPT Capital; Good Seed Ventures GmbH; Lowercarbon Capital LLC; Elevat3 Capital Ltd; Lionheart Ventures 09/13/2021 Heritage Cannabis Holdings Corp. Merida Capital Partners, LLC; Merida Capital Partners IV LP Private Placement Announced 1.5 09/13/2021 Devonian Health Group Inc. Private Placement Closed 0.8 09/13/2021 MustGrow Biologics Corp. Private Placement Announced 1.6 09/13/2021 Cytovia Therapeutics, Inc. Temasek Capital Management Pte. Ltd.; Hangzhou Tigermed Private Placement Closed 45.0 Consulting Co., Ltd; Yunfeng Capital; TF Capital; BioTrack Capital; TG Sino-Dragon Fund 09/13/2021 Shandong Boan Biotechnology Co., Ltd. Yantai Wensen Investment Partnership (Limited Partnership); Private Placement Announced 18.7 Shandong New Kinetic Energy Fund Management Co., Ltd. 09/13/2021 SI Holdings MI, Inc. Private Placement Announced - 09/13/2021 Colossal Biosciences Inc. Capital Factory; Draper Associates, L.P.; Breyer Capital, LLC; Private Placement Closed 15.0 Winklevoss Capital Management LLC; Liquid 2 Ventures; Jazz Venture Partners, L.P.; Bold Capital Partners; Global Space Ventures; First Light Capital Partners; At One Ventures; Climate Capital; Animal Capital 09/13/2021 Alebund Pharmaceuticals The Morningside Group Limited; Eli Lilly Investment Consulting Private Placement Closed 54.5 (Shanghai) Co., Ltd.; Verition Fund Management LLC; Yuan-sheng Suzhou Industrial Park Venture Capital Management Co., Ltd.; 3E Bioventures Capital; Loyal Valley Capital; 3H Health Investment Management; Quan Capital; Sherpa Venture Capital; Octagon Capital Advisors LP; HT Capital 09/13/2021 PT Etana Biotechnologies Indonesia UOB Venture Management Private Limited; Legend Capital Private Placement Closed - Management Co., Ltd.; Innovent Biologics, Inc. 09/13/2021 Daito Pharmaceutical Co.,Ltd. Daiwa Securities Co., Ltd., Investment Arm Private Placement Announced 0.1 09/13/2021 MingMed Biotechnology Co., Ltd. Zhuhai Huajin Capital Co., Ltd.; Fosun RZ Venture Management Co., Private Placement Closed 50.0 Ltd.; Gaorong Capital; Efung Capital; Yingke Innovation Asset Management Co., Ltd.; Yifeng Capital; Oceanpine Capital Limited; Guangzhou Flower City Venture Capital Management Co., Ltd.; Yatsen Holding Limited; JCP Capital; Jifeng Ventures 09/13/2021 Huixin Biotech Shenzhen Co-win Venture Capital Investments Limited Private Placement Closed 1.6 09/17/2021 Enzychem Lifesciences Corporation Public Offering Announced 268.2 09/16/2021 Vaxart, Inc. Public Offering Announced 100.0 09/16/2021 Aptinyx Inc. Public Offering Announced 50.0 09/15/2021 Tanvex BioPharma, Inc. Public Offering Announced 5.5 09/15/2021 Healios K.K. Public Offering Announced 65.6 09/15/2021 Theseus Pharmaceuticals, Inc. Public Offering Announced 100.0 09/15/2021 aTyr Pharma, Inc. Public Offering Closed 75.0 09/15/2021 Herantis Pharma Oyj Public Offering Closed 4.8 09/15/2021 Almirall, S.A. Public Offering Closed 354.5 09/14/2021 Transcenta Holding Limited Public Offering Announced 83.0 09/14/2021 Avalo Therapeutics, Inc. Public Offering Closed 27.5 09/14/2021 ToolGen Incorporated Public Offering Announced - 09/13/2021 Neuren Pharmaceuticals Limited Public Offering Closed 14.6 09/13/2021 Neuren Pharmaceuticals Limited Public Offering Announced 1.5 09/13/2021 MiNK Therapeutics, Inc. Public Offering Announced 50.0 Recent Healthcare Supplies, Equipment and Services Transactions Announcement Date Target/Issuer Buyers/Investors/Sellers